Oxidative stress in Niemann-Pick disease, type C.
暂无分享,去创建一个
W. Pavan | F. Porter | R. Fu | N. Yanjanin | S. Bianconi
[1] M. Patterson,et al. Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C , 2010, Journal of child neurology.
[2] Joseph L. Goldstein,et al. Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol , 2009, Cell.
[3] A. Colell,et al. Mitochondrial Cholesterol Loading Exacerbates Amyloid β Peptide-Induced Inflammation and Neurotoxicity , 2009, The Journal of Neuroscience.
[4] R. Cenedella. Cholesterol Synthesis Inhibitor U18666A and the Role of Sterol Metabolism and Trafficking in Numerous Pathophysiological Processes , 2009, Lipids.
[5] W. Pavan,et al. Linear clinical progression, independent of age of onset, in Niemann–Pick disease, type C , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[6] G. Enns,et al. Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia , 2009, Proceedings of the National Academy of Sciences.
[7] J. Cooper,et al. Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy , 2008, European journal of neurology.
[8] M. Beal,et al. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis , 2008, Nature Clinical Practice Neurology.
[9] A. Galione,et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium , 2008, Nature Medicine.
[10] B. Bembi,et al. Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone , 2008, Journal of cellular and molecular medicine.
[11] D. Ory,et al. Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. , 2008, The Journal of clinical investigation.
[12] N. Okudan,et al. Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions. , 2008, Methods and Findings in Experimental and Clinical Pharmacology.
[13] S. Gale,et al. Niemann-Pick Type C1 I1061T Mutant Encodes a Functional Protein That Is Selected for Endoplasmic Reticulum-associated Degradation Due to Protein Misfolding* , 2008, Journal of Biological Chemistry.
[14] J. Dingemanse,et al. Influence of Food Intake on the Pharmacokinetics of Miglustat, an Inhibitor of Glucosylceramide Synthase , 2007, Journal of clinical pharmacology.
[15] M. Patterson,et al. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study , 2007, The Lancet Neurology.
[16] A. Colell,et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. , 2006, Cell metabolism.
[17] D. Galati,et al. Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction , 2006, The Journal of Neuroscience.
[18] M. Rogero,et al. Free radical scavenger and antioxidant capacity correlation of α-tocopherol and Trolox measured by three in vitro methodologies , 2006, International journal of food sciences and nutrition.
[19] JoAnn Buchanan,et al. Cell-Autonomous Death of Cerebellar Purkinje Neurons with Autophagy in Niemann-Pick Type C Disease , 2005, PLoS genetics.
[20] M. Michikawa,et al. Altered Cholesterol Metabolism in Niemann-Pick Type C1 Mouse Brains Affects Mitochondrial Function* , 2005, Journal of Biological Chemistry.
[21] K. Okamoto,et al. An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients , 2005, Journal of the Neurological Sciences.
[22] Mushfiquddin Khan,et al. A Novel Role of Lactosylceramide in the Regulation of Lipopolysaccharide/Interferon-γ-Mediated Inducible Nitric Oxide Synthase Gene Expression: Implications for Neuroinflammatory Diseases , 2004, The Journal of Neuroscience.
[23] S. Mellon,et al. Niemann–Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone , 2004, Nature Medicine.
[24] M. V. Miles,et al. Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases. , 2004, American journal of clinical pathology.
[25] R. Mayeux,et al. A comparison of family history of psychiatric disorders among patients with early- and late-onset Alzheimer's disease. , 2004, The Journal of neuropsychiatry and clinical neurosciences.
[26] Danielle A. Simmons,et al. Postnatal development of inflammation in a murine model of Niemann–Pick type C disease: immunohistochemical observations of microglia and astroglia , 2003, Experimental Neurology.
[27] M. Vanier. Niemann-Pick disease type C , 2010, Orphanet journal of rare diseases.
[28] M. Gondré-Lewis,et al. Cholesterol Accumulation in NPC1-Deficient Neurons Is Ganglioside Dependent , 2003, Current Biology.
[29] J. Crowley,et al. NPC1 and NPC2 Regulate Cellular Cholesterol Homeostasis through Generation of Low Density Lipoprotein Cholesterol-derived Oxysterols* , 2003, Journal of Biological Chemistry.
[30] Ann M Stock,et al. Structure of a cholesterol-binding protein deficient in Niemann–Pick type C2 disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] Ole A. Andreassen,et al. Therapeutic Effects of Coenzyme Q10 and Remacemide in Transgenic Mouse Models of Huntington's Disease , 2002, The Journal of Neuroscience.
[32] S. Walkley,et al. Critical role for glycosphingolipids in Niemann-Pick disease type C , 2001, Current Biology.
[33] H. Ninomiya,et al. [Niemann-Pick disease type C]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[34] R. Wattiaux,et al. Identification of HE1 as the second gene of Niemann-Pick C disease. , 2000, Science.
[35] Yiannis A. Ioannou,et al. Topological Analysis of Niemann-Pick C1 Protein Reveals That the Membrane Orientation of the Putative Sterol-sensing Domain Is Identical to Those of 3-Hydroxy-3-methylglutaryl-CoA Reductase and Sterol Regulatory Element Binding Protein Cleavage-activating Protein* , 2000, The Journal of Biological Chemistry.
[36] M. Hüttemann,et al. Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. , 2000, Free radical biology & medicine.
[37] K. G. Coleman,et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.
[38] G. Dallner,et al. Peroxisomal Impairment in Niemann-Pick Type C Disease* , 1997, The Journal of Biological Chemistry.
[39] L. Landi,et al. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] U. Hellman,et al. Muscarinic toxins from the black mamba Dendroaspis polylepis. , 1995, European journal of biochemistry.
[41] J. Cleary,et al. Prevention of Tocopherol-mediated Peroxidation in Ubiquinol-10-free Human Low Density Lipoprotein (*) , 1995, The Journal of Biological Chemistry.
[42] R. Brady,et al. The Niemann-Pick C lesion and its relationship to the intracellular distribution and utilization of LDL cholesterol. , 1994, Biochimica et biophysica acta.
[43] O. Gabrielli,et al. Coenzyme Q10 and oxidative imbalance in Down syndrome: Biochemical and clinical aspects , 2008, BioFactors.
[44] R. Proia,et al. Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. , 2005, Molecular genetics and metabolism.
[45] Y. Yamamoto,et al. Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress. , 1997, Molecular aspects of medicine.
[46] C. Walling,et al. Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.